To test ST2 neutralization in another immunocompetent clinically relevant model of leukemia, we used the epigenetically mutated DNMT3A/FLT3ITD model28 that developed frequent extramedullary leukemia in the spleen and liver. Here, DNMT3A is linked to leukemia.